C. Steen-Louws

IL4-10 Fusion Protein Is a Novel Drug to Treat Persistent Inflammatory Pain

C. Hack, A. Kavelaars, J. V. van Roon, 2016, The Journal of Neuroscience.

IL4-10 fusion protein has chondroprotective, anti-inflammatory and potentially analgesic effects in the treatment of osteoarthritis.

M. Tryfonidou, C. Hack, N. Eijkelkamp, 2018, Osteoarthritis and cartilage.

Sialic Acid-Engineered IL4–10 Fusion Protein is Bioactive and Rapidly Cleared from the Circulation

L. Boon, A. Huitema, C. Hack, 2019, Pharmaceutical Research.

IL4‐10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10

N. Eijkelkamp, F. Lafeber, C. Hack, 2018, Clinical and experimental immunology.

Cytokine receptor clustering in sensory neurons with an engineered cytokine fusion protein triggers unique pain resolution pathways

L. Koenderman, C. Hack, N. Eijkelkamp, 2021, Proceedings of the National Academy of Sciences.

Development of Recombinant Proteins to Treat Chronic Pain.

N. Eijkelkamp, J. Prado, E. Hack, 2018, Journal of visualized experiments : JoVE.

IL4-10 synerkine to induce direct and indirect structural cartilage repair in osteoarthritis

S. Mastbergen, C. Hack, F. Lafeber, 2015 .